Press - 2017

2017-06-29, PRESS

Chemical Biology Consortium Sweden enters research collaboration with AstraZeneca

Chemical Biology Consortium Sweden (CBCS), an integrated part of SciLifeLab, today announced a new research collaboration with AstraZeneca. The partnership will give Swedish academic researchers access to AstraZeneca’s annotated small molecule compound library with the aim of identifying novel protein targets aligned to key unmet medical needs. Projects are expected to focus on so-called phenotypic […]

2017-06-28, PRESS

National network for future leaders in life science launched by SciLifeLab and Wallenberg Centers for Molecular Medicine

SciLifeLab (Science for Life Laboratory), a national center for biomolecular sciences, and the Wallenberg Centers for Molecular Medicine (WCMM) in Gothenburg, Linköping, Lund and Umeå have formed a collaborative network to bring together the future leaders of life science and molecular medicine in Sweden. SciLifeLab and WCMM have initiated an official collaboration, co-funded by a […]

2017-04-20, PRESS

SciLifeLab offers funding for national genomics studies

SciLifeLab welcomes applications for Swedish research projects based on next generation DNA sequencing. In total, this third call will provide 30 million SEK in support for sequence analysis of unique and well-characterized sample collections to study either the genetic basis of disease or environmental effects on biodiversity. The Swedish Genomes Program and the Swedish Biodiversity […]

2017-01-16, PRESS

Pelago Bioscience and CBCS at SciLifeLab enters collaboration agreement

Pelago Bioscience AB and Chemical Biology Consortium Sweden (CBCS), the chemical biology facility at Karolinska Institutet and SciLifeLab (Science for Life Laboratory) today announced that they will collaborate to develop high throughput automated CETSA®-based Target Engagement Assays for multiple targets. The collaboration is based on expanding Pelago’s CETSA technology capabilities and will enable screening of […]